Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Dogwood Therapeutics Inc.

    NASDAQ: DWTX · Real-Time Price · USD
    4.73
    -0.15 (-3.17%)
    At close: Jun 06, 2025, 3:59 PM
    4.80
    1.48%
    After-hours: Jun 06, 2025, 05:45 PM EDT

    Dogwood Therapeutics Statistics

    Share Statistics

    Dogwood Therapeutics has 1.91M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 1.91M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 13,765

    FTD / Avg. Volume

    n/a
    		 0.77%

    Short Selling Information

    The latest short interest is 191.28K, so 10.01% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 191.28K

    Short % of Shares Out

    n/a
    		 10.01%

    Short % of Float

    n/a
    		 11.34%

    Short Ratio (days to cover)

    n/a
    		 1.2

    Valuation Ratios

    The PE ratio is -0.21 and the forward PE ratio is -1.24. Dogwood Therapeutics's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 -0.21

    Forward PE

    n/a
    		 -1.24

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 0.04

    P/FCF Ratio

    n/a
    		 -0.29

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Dogwood Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.21, with a Debt / Equity ratio of 0.24.

    Current Ratio

    n/a
    		 5.21

    Quick Ratio

    n/a
    		 5.21

    Debt / Equity

    n/a
    		 0.24

    Debt / EBITDA

    n/a
    		 -1.27

    Debt / FCF

    n/a
    		 -1.77

    Interest Coverage

    n/a
    		 -132.63

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,029,143.67

    Employee Count

    n/a
    		 12

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -503

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -17.02% in the last 52 weeks. The beta is 1.9, so Dogwood Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.9

    52-Week Price Change

    n/a
    		 -17.02%

    50-Day Moving Average

    n/a
    		 4.88

    200-Day Moving Average

    n/a
    		 4.92

    Relative Strength Index (RSI)

    n/a
    		 45

    Average Volume (20 Days)

    n/a
    		 1,796,187

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -12.23M

    Net Income

    n/a
    		 -12.35M

    EBITDA

    n/a
    		 -12.25M

    EBIT

    n/a
    		 -12.26M

    Earnings Per Share (EPS)

    n/a
    		 -9.42
    Full Income Statement

    Balance Sheet

    The company has 14.85M in cash and 15.59M in debt, giving a net cash position of -737.71K.

    Cash & Cash Equivalents

    n/a
    		 14.85M

    Total Debt

    n/a
    		 15.59M

    Net Cash

    n/a
    		 -737.71K

    Retained Earnings

    n/a
    		 -73.82M

    Total Assets

    n/a
    		 96.98M

    Working Capital

    n/a
    		 16.58M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -8.79M and capital expenditures 0, giving a free cash flow of -8.79M.

    Operating Cash Flow

    n/a
    		 -8.79M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -8.79M

    FCF Per Share

    n/a
    		 -8.55
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    DWTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for DWTX is $10, which is 111.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 111.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -1.68

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist